# Waldenström Macroglobulinemia Diagnosed by Ultrasonography‐Guided Biopsy of the Right Perinephric Tumor

**Authors:** Shingo Morinaga, Shigeyuki Aoki, Motoi Tobiume, Genya Nishikawa, Fusako Higuchi, Yuusuke Ikenohata, Manabu Honda, Hiroe Kubo, Tomoko Sawada, Yoshiaki Yamada

PMC · DOI: 10.1002/iju5.70022 · IJU Case Reports · 2025-04-09

## TL;DR

A rare case of Waldenström macroglobulinemia was diagnosed using ultrasound-guided biopsy of a kidney tumor, enabling early treatment.

## Contribution

Demonstrates the effectiveness of ultrasonography-guided biopsy in diagnosing rare perinephric lymphomas.

## Key findings

- Ultrasound-guided biopsy confirmed lymphoplasmacytic lymphoma with characteristic markers CD20, CD138, and IgM.
- Bone marrow infiltration was confirmed, supporting the diagnosis of Waldenström macroglobulinemia.
- Treatment with bortezomib, cyclophosphamide, and dexamethasone showed partial response after 12 months.

## Abstract

Waldenström macroglobulinemia is a low‐grade B‐cell lymphoma characterized by lymphoplasmacytic lymphoma infiltration of the bone marrow and immunoglobulin M (IgM) protein.

An 80s‐year‐old male presented to our hospital with chief complaints of weight loss and general fatigue. Computed tomography (CT) showed homogeneous tumor around the kidney with elevated soluble Interleukin‐2 receptor, serum IgM, and β2‐microglobulin levels. Histopathological analysis by ultrasonography‐guided biopsy revealed dense lymphocytic proliferation, plasmacytoid differentiation, and Dutcher bodies, positive for CD20, CD138, and IgM, but negative for CD3 and CD5, consistent with lymphoplasmacytic lymphoma. Bone marrow biopsy revealed infiltration of the lymphoplasmacytic lymphoma. The patient received four courses of bortezomib, cyclophosphamide, and dexamethasone along with dexamethasone, rituximab, and cyclophosphamide therapy. Twelve months after treatment, CT revealed only slightly enlarged abdominal para‐aortic lymph nodes.

Malignant lymphoma in perinephric lesions is a relatively rare condition; however, a definitive diagnosis can be obtained by ultrasound‐guided biopsy, allowing early initiation.

## Linked entities

- **Proteins:** MS4A1 (membrane spanning 4-domains A1), SDC1 (syndecan 1), CD40LG (CD40 ligand), cd.3 (Cd.3 conserved hypothetical protein), CD5 (CD5 molecule)
- **Chemicals:** bortezomib (PubChem CID 387447), cyclophosphamide (PubChem CID 2907), dexamethasone (PubChem CID 5743)
- **Diseases:** Waldenström macroglobulinemia (MONDO:0100280), lymphoplasmacytic lymphoma (MONDO:0000432)

## Full-text entities

- **Genes:** KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, HLA-G (major histocompatibility complex, class I, G) [NCBI Gene 3135] {aka MHC-G}, CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}
- **Diseases:** Malignant lymphoma (MESH:D008223), weight loss (MESH:D015431), Waldenstrom Macroglobulinemia (MESH:D008258), tumor (MESH:D009369), fatigue (MESH:D005221), B-cell lymphoma (MESH:D016393), Perinephric Tumor (MESH:D010501)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12055227/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12055227/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12055227/full.md

---
Source: https://tomesphere.com/paper/PMC12055227